Emily R. Caton, Yezhi Pan, Kiana M. Kiser, Caroline R. Haddaway, Wayne A. Bryden, Michael McLoughlin, Marek A. Mirski, Robert H. Christenson, Cindy C. Sevilla, Shuo Chen, Sheng Feng, Dapeng Chen
{"title":"Multiplexed protease activity profiling for host response-based Sepsis diagnosis","authors":"Emily R. Caton, Yezhi Pan, Kiana M. Kiser, Caroline R. Haddaway, Wayne A. Bryden, Michael McLoughlin, Marek A. Mirski, Robert H. Christenson, Cindy C. Sevilla, Shuo Chen, Sheng Feng, Dapeng Chen","doi":"10.1016/j.cca.2026.122903","DOIUrl":null,"url":null,"abstract":"<div><div>Human proteases play major roles in various pathological conditions, including dysregulated immune responses in sepsis, making them strong candidates for developing diagnostic markers. Despite this potential, the process of developing protease-based diagnostic tools has remained slow due to significant technical barriers associated with measuring protease activity, mainly stemming from the vast diversity of human proteases and the lack of substrate specificity, which complicates the interpretation of activity profiles. In this work, we advanced the current state of assay development by engineering substrate molecules and implementing an analytical approach based on mass spectrometry. Specifically, we developed a novel approach to chemically modify protease substrates for human neutrophil elastase (HNE) and matrix metalloproteinases (MMPs) to enhance specificity and generate unique mass-to-charge signatures, allowing the deconvolution of protease activities. We then integrated the modified substrates into a mass spectrometry-based platform for quantifying multiple protease activities within a single analytical run. We applied the assay to spared plasma samples and demonstrated that the assay detects distinct protease activity profiles. We further demonstrated that the assay achieved a diagnostic sensitivity of 88% and specificity of 87% for sepsis detection within a three-hour timeframe.</div></div><div><h3>One Sentence Summary</h3><div>We developed a novel multiplexed protease activity profiling approach to quantify immune responses and improve sepsis diagnosis.</div></div>","PeriodicalId":10205,"journal":{"name":"Clinica Chimica Acta","volume":"594 ","pages":"Article 122903"},"PeriodicalIF":4.1000,"publicationDate":"2027-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinica Chimica Acta","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0009898126020851","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/10/19 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Human proteases play major roles in various pathological conditions, including dysregulated immune responses in sepsis, making them strong candidates for developing diagnostic markers. Despite this potential, the process of developing protease-based diagnostic tools has remained slow due to significant technical barriers associated with measuring protease activity, mainly stemming from the vast diversity of human proteases and the lack of substrate specificity, which complicates the interpretation of activity profiles. In this work, we advanced the current state of assay development by engineering substrate molecules and implementing an analytical approach based on mass spectrometry. Specifically, we developed a novel approach to chemically modify protease substrates for human neutrophil elastase (HNE) and matrix metalloproteinases (MMPs) to enhance specificity and generate unique mass-to-charge signatures, allowing the deconvolution of protease activities. We then integrated the modified substrates into a mass spectrometry-based platform for quantifying multiple protease activities within a single analytical run. We applied the assay to spared plasma samples and demonstrated that the assay detects distinct protease activity profiles. We further demonstrated that the assay achieved a diagnostic sensitivity of 88% and specificity of 87% for sepsis detection within a three-hour timeframe.
One Sentence Summary
We developed a novel multiplexed protease activity profiling approach to quantify immune responses and improve sepsis diagnosis.
期刊介绍:
The Official Journal of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)
Clinica Chimica Acta is a high-quality journal which publishes original Research Communications in the field of clinical chemistry and laboratory medicine, defined as the diagnostic application of chemistry, biochemistry, immunochemistry, biochemical aspects of hematology, toxicology, and molecular biology to the study of human disease in body fluids and cells.
The objective of the journal is to publish novel information leading to a better understanding of biological mechanisms of human diseases, their prevention, diagnosis, and patient management. Reports of an applied clinical character are also welcome. Papers concerned with normal metabolic processes or with constituents of normal cells or body fluids, such as reports of experimental or clinical studies in animals, are only considered when they are clearly and directly relevant to human disease. Evaluation of commercial products have a low priority for publication, unless they are novel or represent a technological breakthrough. Studies dealing with effects of drugs and natural products and studies dealing with the redox status in various diseases are not within the journal''s scope. Development and evaluation of novel analytical methodologies where applicable to diagnostic clinical chemistry and laboratory medicine, including point-of-care testing, and topics on laboratory management and informatics will also be considered. Studies focused on emerging diagnostic technologies and (big) data analysis procedures including digitalization, mobile Health, and artificial Intelligence applied to Laboratory Medicine are also of interest.